TABLE 2.
Model and data set | PEc (μg/ml) | MPEd (%) | MAPEe (%) |
---|---|---|---|
PPRU study modela | |||
PPRU study | 0.132 (−4.76, 8.39) | 15.3 (−51.1, 153) | 35.7 |
Prophylaxis study | 0.429 (−3.31, 11.2) | 41.9 (−43.3, 302) | 57.6 |
Merged | 0.338 (−6.10, 9.86) | 33.7 (−64.4, 296) | 59.2 |
Prophylaxis study modelb | |||
Prophylaxis study | 0.339 (−3.61, 3.10) | 12.2 (−47.4, 141) | 31.8 |
PPRU study | 2.45 (−4.05, 65.4) | 188 (−40.3, 848) | 195 |
Merged | −0.245 (−5.15, 9.66) | 20.1 (−66.4, 250) | 53.9 |
Patients in the PPRU study received fluconazole at 3 to 12 mg/kg i.v., given every 1 to 3 days.
Patients in the prophylaxis study received fluconazole at 6 mg/kg twice weekly (Tuesdays and Fridays) i.v. or p.o.
PE, prediction error, which is presented as the median (2.5th percentile, 97.5th percentile).
MPE, mean prediction error, which is presented as the mean (2.5th percentile, 97.5th percentile).
MAPE, mean absolute prediction error.